Search

Author/Creator Homony, Brenda

1. 1617Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study. (December 2014)

Authors:
Teppler, Hedy; Shuldyakov, Andrey; Gankina, Natalia; Kulagin, Valeriy; Nagimova, Firaya; Shimonova, Tatiana; Sonin, Dmitriy; Sotnikov, Vladimir; Zakharova, Natalia; Homony, Brenda; Wang, Deng; Moshkovich, Grigoriy
Journal:
Open forum infectious diseases
Issue:
Volume 1(2014)Supplement 1
Page Start:
S431
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use. Issue 1 (21st October 2021)

Authors:
Mills, Alexander; Myers, Laurie; Raudenbush, Casey; Vossen, David A.; Teppler, Hedy; Miteva, Yanna R.; Seeley, Suzanne; Homony, Brenda; Straus, Walter L.
Journal:
Pediatric infectious disease journal
Issue:
Volume 41:Issue 1(2022)
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use. Issue 1 (January 2022)

Authors:
Mills, Alexander; Myers, Laurie; Raudenbush, Casey; Vossen, David A.; Teppler, Hedy; Miteva, Yanna R.; Seeley, Suzanne; Homony, Brenda; Straus, Walter L.
Journal:
Pediatric infectious disease journal
Issue:
Volume 41:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1–Infected Children Aged 2 Through 18 Years. (21st October 2013)

Authors:
Nachman, Sharon; Zheng, Nan; Acosta, Edward P.; Teppler, Hedy; Homony, Brenda; Graham, Bobbie; Fenton, Terence; Xu, Xia; Wenning, Larissa; Spector, Stephen A.; Frenkel, Lisa M.; Alvero, Carmelita; Worrell, Carol; Handelsman, Edward; Wiznia, Andrew; Moultrie, Harry; Kindra, Gurpreet; Sanders, Marg...
Journal:
Clinical infectious diseases
Issue:
Volume 58:Number 3(2014)
Page Start:
413
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV‐infected children 4 weeks to 18 years of age. (13th April 2015)

Authors:
Rizk, Matthew L.; Du, Lihong; Bennetto‐Hood, Chantelle; Wenning, Larissa; Teppler, Hedy; Homony, Brenda; Graham, Bobbie; Fry, Carrie; Nachman, Sharon; Wiznia, Andrew; Worrell, Carol; Smith, Betsy; Acosta, Edward P.
Journal:
Journal of clinical pharmacology
Issue:
Volume 55:Number 7(2015:Jul.)
Page Start:
748
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. Issue 11 (November 2017)

Authors:
Cahn, Pedro; Kaplan, Richard; Sax, Paul E; Squires, Kathleen; Molina, Jean-Michel; Avihingsanon, Anchalee; Ratanasuwan, Winai; Rojas, Evelyn; Rassool, Mohammed; Bloch, Mark; Vandekerckhove, Linos; Ruane, Peter; Yazdanpanah, Yazdan; Katlama, Christine; Xu, Xia; Rodgers, Anthony; East, Lilly; Wenni...
Journal:
Lancet
Issue:
Volume 4:Issue 11(2017)
Page Start:
e486
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial. (15th August 2018)

Authors:
Cahn, Pedro; Sax, Paul E.; Squires, Kathleen; Molina, Jean-Michel; Ratanasuwan, Winai; Rassool, Mohammed; Bloch, Mark; Xu, Xia; Zhou, Yan; Homony, Brenda; Hepler, Deborah; Teppler, Hedy; Hanna, George J.; Nguyen, Bach-Yen; Greaves, Wayne
Journal:
Journal of acquired immune deficiency syndromes
Issue:
Volume 78:Number 5(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial. Issue 12 (December 2018)

Authors:
Nachman, Sharon; Alvero, Carmelita; Teppler, Hedy; Homony, Brenda; Rodgers, Anthony J; Graham, Bobbie L; Fenton, Terence; Frenkel, Lisa M; Browning, Renee S; Hazra, Rohan; Wiznia, Andrew A
Journal:
Lancet
Issue:
Volume 5:Issue 12(2018)
Page Start:
e715
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗